Comparison of Graft Acquisition and Early Direct Charges of Haploidentical Related Donor Transplantation versus Umbilical Cord Blood Transplantation

Abraham S. Kanate(HonorHealth), Saurabh Chhabra(Medical College of Wisconsin), Anikó Szabó(University of Wisconsin–Madison), Rachel Grulke(Medical College of Wisconsin), Parameswaran Hari(Medical College of Wisconsin), Kathryn Bower(West Virginia University), Nilay Shah(Levine Cancer Institute), Michael Craig(Edith Cowan University), Marcelo C. Pasquini(Cleveland Clinic), Nirav N. Shah(Medical College of Wisconsin), Renju Raj(Medical College of Wisconsin), Aaron Cumpston(West Virginia University Hospitals), Kelly G. Ross(West Virginia University), Mehdi Hamadani(Medical College of Wisconsin)
Transplantation and Cellular Therapy
March 14, 2019
10.1016/j.bbmt.2019.03.013
Cited by 19

Related Papers

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
|The Lancet|2021|1.7k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664